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286 The Journal of Thoracic and CardioObjective: This study was undertaken to evaluate the late outcomes of reconstruc-
tion of the intervalvular fibrous body during aortic and mitral valve replacement.
Methods: Seventy-six consecutive patients underwent reconstruction of the inter-
valvular fibrous body with replacement of the mitral and aortic valves. There were
35 men and 41 women whose mean age was 58  12 years. Additional procedures
were circumferential reconstruction of the mitral annulus in 27 patients, tricuspid
valve repair in 21, coronary artery bypass in 15, and aortic root replacement in 4.
Indications for the operation were active infective endocarditis with abscess in 15
patients, extensive calcification of the mitral annulus and interventricular fibrous
body in 24, lack of fibrous tissue to secure a prosthetic valve in 17, and treatment
or prevention of patient-prosthesis mismatch in 20. Fifty-five patients had under-
gone one or more previous valve operations, and 52 (68%) were in functional class
IV. The mean follow-up was 47  47 months, and it was complete.
Results: There were 8 (10%) operative and 18 (24%) late deaths. The 10-year
survival was 50%  9%. There were 15 reoperations in 12 patients: 7 for prosthetic
valve endocarditis (5 early, 2 late), 7 for patch or valve dehiscence (3 early, 4 late),
and 1 for structural valve deterioration. All but 2 reoperations were re-reconstruction
of the intervalvular fibrous body and double valve replacement. The 10-year
freedom from reoperation was 73%  7%.
Conclusion: Reconstruction of the intervalvular fibrous body during double valve
replacement is a technically challenging operation, but it is useful in patients with
complex valve pathology for whom no alternative procedure is available.
Reconstruction of the intervalvular fibrous body during aortic andmitral valve replacement may be the only alternative to treat somepatients with extensive calcification of the base of the heart, activeinfective endocarditis with abscess, inadequate intervalvular fi-brous tissue to secure a prosthetic valve because of multiple pre-vious operations, or a need to prevent or treat patient-prosthesis
mismatch.1-6 Glutaraldehyde-fixed bovine pericardium and Dacron polyester fabric
have been used as patch materials, with similar early results.1 The long-term results
of these operations remain unknown. This study is an analysis of the early and late
outcomes of reconstruction of the intervalvular fibrous body during aortic and mitral
valve replacement.
Patients and Methods
Between 1985 and 2002, a total of 76 patients underwent reconstruction of the
intervalvular fibrous body with replacement of the mitral and aortic valves by a
single surgeon. There were 35 men and 41 women, and the mean age was 58  12
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CDyears (range 26-80 years). The main indications for opera-
tion were congestive heart failure in 61 patients (80%) and
infective endocarditis with aortic root abscess in 15 (20%).
Fifty-two patients (68%) were in New York Heart Associ-
ation functional class IV, 19 (25%) in class III, and 5 (7%)
in class II. Fifty-five patients (72%) had undergone previous
operations, including mitral valve replacement in 47 and
aortic valve replacement in 44. Fourteen (18%) patients had
coronary artery disease. The left ventricular ejection frac-
tion was greater than 60% in 10 (13%) patients, 41% to 59%
in 49 (54%), 20% to 40% in 13 (17%), and unknown in 4
(5%). Thirty-six (47%) patients were operated on electively,
35 (47%) urgently, and 5 (6%) as an emergency.
Operations
The operative technique has previously been described.1 It
consisted of extending the aortotomy into the noncoronary
aortic sinus, into the intervalvular fibrous body and dome of
the left atrium toward the right pulmonary artery, exposing
both the left ventricular inflow and outflow tracts. The
extensiveness of the resection and reconstruction depended
on the pathology. Patients with abscess had more extensive
resection. After resection of all infected, calcified, and ab-
normal tissues, circumferential reconstruction of the mitral
annulus was required in cases of posterior annular destruc-
tion as a result of abscess in the mitral annulus or extensive
degenerative calcification.1,3 In these cases, the reconstruc-
tion of the mitral annulus was achieved by suturing a large
strip of glutaraldehyde bovine pericardium patch to the
endocardium of the left ventricle from the lateral to the
medial fibrous trigones. Approximately two thirds of the
circumference of a prosthetic mitral valve was secured to
the patch posteriorly. If the native mitral annulus was free of
disease, the prosthetic valve circumference was secured to
the native posterior mitral annulus. A double triangular
shaped patch of Dacron polyester fabric or bovine pericar-
TABLE 1. Operative data
Operations performed
Reconstruction of intervalvular fibrous body 76 (100%)
Circumferential reconstruction of mitral annulus 26 (34%)
Aortic root replacement 4 (5%)
Tricuspid valve repair 21 (28%)
Coronary artery bypass grafting 15 (20%)
Patch material
Bovine pericardium 42 (55%)
Dacron fabric 34 (45%)
Prosthetic valves implanted
Mechanical 49 (64%)
Bioprosthetic 27 (36%)
Aortic crossclamp time (min, mean  SD) 127  27
Cardiopulmonary bypass time (min, mean  SD) 152  31dium was sutured to the lateral and medial fibrous trigones
The Journal of Thoraciand to the superior aspect of the prosthetic mitral valve. The
outer patch was used to close the dome of the left atrium and
the inner patch to reconstruct the aortic root. An aortic
prosthetic valve was implanted in the aortic position by
securing it to the native aortic annulus and to the patch. In
patients who underwent elective aortic and mitral valve
replacement to treat patient-prosthesis mismatch, the inter-
valvular fibrous body was simply divided, and the recon-
struction proceeded in the same manner to enlarge both
annuli. A small number of patients required aortic root
replacement with reimplantation of the coronary arteries.
Indications for the reconstruction of the intervalvular
fibrous body were active infective endocarditis with abscess
in 15 patients (20%), extensive calcification in 24 (32%),
lack of fibrous tissue to secure the prosthetic valve because
of multiple previous operations in 17 (22%), and treatment
or prevention of patient-prosthesis mismatch in 20 (26%).
All patients had anticoagulation with warfarin sodium
during the first 3 postoperative months if they had biopros-
thetic aortic and mitral valves and permanently if they had
mechanical valves or were in atrial fibrillation. Table 1
shows the operative data.
Data Acquisition and Follow-up
The ethics committee of our institution approved this study.
The heart valve surgery database was reviewed for demo-
graphic, operative, perioperative, and outcome data.
Follow-up was obtained through questionnaires, telephone
interviews, and outpatient chart review. The longest fol-
low-up was 162 months (mean of 47  47 months), and
follow-up was 100% complete. Most patients had multiple
echocardiographic studies through the years, and every pa-
tient had at least one study.
Statistical Analysis
All data were analyzed with SAS version 8.1 (SAS Institute,
Figure 1. Long-term survival.Inc, Cary, NC). Continuous variables are reported as mean
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(unless otherwise noted). Categoric variables are reported as
frequencies. Late outcomes were analyzed with the Kaplan-
Meier method.
Results
Operative Mortality and Morbidity
There were 8 operative deaths (10%): 3 of multiorgan
failure, 2 of myocardial infarction, 1 of intracranial bleed-
ing, and 2 from technical errors early on the series. Five
patients (7%) required reexploration of the mediastinum for
bleeding, and 18 (24%) patients had development of heart
block requiring placement of a permanent pacemaker. Three
Figure 2. Freedom from prosthetic valve endocarditis (SBE).
TABLE 2. Operative failures in reconstruction of the interv
Patient No. Indication
I
r
1 Endocarditis PVE
2 Previous operations PVE
3 Extensive calcification PVE
4 Previous operations PVE
Patc
5 Extensive calcification PVE
Patc
6 Extensive calcification PVE
7 Small annuli PVE
8 Previous operations Valve
9 Previous operations Valve
Valve
Patc
10 Previous operations Patc
11 Previous operations Valve
12 Previous operations Para
PVE, Prosthetic valve endocarditis.
*This patient underwent heart transplant at another institution and died.
†This patient had repair of paravalvular dehiscence without taking downpatients had postoperative stroke; 1 died (intracranial bleed-
288 The Journal of Thoracic and Cardiovascular Surgery ● Febring), 1 was left with a residual neurologic deficit, and 1
recovered completely.
Late Mortality and Morbidity
There were 18 late deaths (24%). The causes of late death
were congestive heart failure in 6 patients, sudden death in
2, infective endocarditis in 2, myocardial infarction in 1,
paravalvular leak in 1, septicemia in 1, bowel ischemia in 1,
lung cancer in 1, complications after a heart transplant in 1,
and reoperations for prosthetic valve endocarditis in 1 and
for patch dehiscence in 1. The 10-year survival was 50% 
9%, as illustrated in Figure 1. There were 3 strokes: 1
patient died, and 2 had complete neurologic recovery. The
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2 late. All of these patients underwent reoperation, and 1
died. The 10-year freedom from prosthetic valve endocar-
ditis was 85%  5% (Figure 2).
Reoperations
Twelve patients underwent 15 reoperations (Figure 3). Nine
of the 12 patients who required reoperations had undergone
circumferential reconstruction of the mitral annulus. Table 2
gives the indications for first reconstruction of the interval-
vular fibrous body, the reasons for the first or subsequent
reoperation, the time intervals between them, and the out-
comes. The reasons for reoperation were prosthetic valve
endocarditis in 7 patients, patch or prosthetic valve dehis-
cence in 7, and bioprosthetic valve failure in 1. One patient
with late patch or valve dehiscence had a heart transplant at
another institution and died. We reoperated on the remain-
ing 11 patients, 2 of whom died. Repeated reconstruction of
the intervalvular fibrous body was performed in all but 1
patient, who had only repair of valve dehiscence.
One additional patient had late patch or valve dehiscence
and was not offered reoperation because of prohibitively
high operative risk related to comorbidities. This patient
died 2 years later in congestive heart failure.
Valve-Related Complications and Functional Class
A total of 23 patients (30%) had valve-related complica-
tions. The freedom from valve-related mortality and mor-
bidity at 10 years was 60%  7%. At the last follow-up
contact, 50 patients were alive. Among them 25 patients
were in New York Heart Association functional class I, 13
were in class II, 11 were in class III, and 1 was in class IV.
All 50 patients had normally functioning prosthetic valves
at the latest echocardiographic study.
Discussion
A fibrous curtain that extends from the lateral to the medial
fibrous trigones separates the aortic and mitral valves. This
close relationship between the aortic and mitral valves lim-
its the combined enlargement of both the aortic and mitral
valve annuli to the area between the two trigones. Manou-
guian and associates7 described an operative procedure in a
canine model whereby both the aortic and mitral annuli
could be enlarged by cutting into the intervalvular fibrous
body. This operation was performed in children with small
annuli because of rheumatic valve disease.8,9 The indica-
tions were extended to the treatment of infective endocar-
ditis with abscess of the intervalvular fibrous body, exten-
sive calcification of the mitral annulus, and the lack of
fibrous tissue to secure prosthetic valves because of multiple
previous valve operations.1,3-6
We reported our initial experience with reconstruction of
the intervalvular fibrous during aortic and mitral valve re-
The Journal of Thoraciplacement in 1997.1 The mortality and morbidity were high
at 16%, and we were concerned about the durability of the
glutaraldehyde-treated bovine pericardium used for the re-
construction of the base of the heart. As the experience with
the operation increased, the operative mortality decreased
and has become more dependent on the pathology and
patient’s clinical presentation than on technical problems.
This is a complex operation, however, and a sound knowl-
edge of the anatomic relationships of the various compo-
nents along the left atrioventricular groove and interventric-
ular septum is necessary to perform it. After removal of the
aortic and the mitral valves through the aortic root and dome
of the left atrium, the left ventricular inflow and outflow
tracts become a single orifice, which has to accommodate
two prosthetic valves. Thus an excessively large prosthetic
mitral valve fills the entire base of the ventricle and leaves
no room for a prosthetic aortic valve. Conversely, if the
heart is enlarged and a small mitral valve is implanted, it
will deform the base of the heart. The size of the mitral
valve prosthesis can be estimated by placing the valve
manufacturer’s sizer into the mitral annulus and observing
how close it comes to the interventricular septum. The upper
end of the valve sizer should be approximately 1 cm below
the level of the aortic annulus. In addition, less than a third
of its circumference should correspond to the distance be-
tween the lateral and medial fibrous trigones. Once a pros-
thetic valve is secured to the mitral annulus, the patch used
to reconstruct the intervalvular fibrous body is as wide as
the gap in between the lateral and medial fibrous trigones,
usually 2 to 3 cm. The areas where the patch joins the mitral
annulus and the sewing ring of the prosthetic valve are
probably the most important to prevent patch or valve
dehiscence. This patch is then sutured to the aortic root, and
a prosthetic aortic valve is secured to the native aortic
annulus and the patch. The dome of the left atrium should be
closed before implantation of the aortic valve.
Reconstructions that involve the posterior part of the
mitral annulus are even more complex.5 Actually, 9 of 12
patients who needed reoperations had undergone recon-
struction of the posterior mitral annulus in addition to re-
construction of the intervalvular fibrous body.
In cases of paravalvular abscess, we believe that radical
resection of all infected tissues is more important than the
type of patch material or valve used for the reconstruction.10
Most surgeons, however, consider aortic valve homografts
ideally suited in these circumstances and also more resistant
to reinfection.11 Aortic valve homograft with retained ante-
rior leaflet of the mitral valve can be used to reconstruct the
intervalvular fibrous body. We have used this technique in
a few patients with aortic root abscess in whom the native
mitral valve was repaired by replacing part of its base and
the intervalvular fibrous body with the anterior leaflet of the
c and Cardiovascular Surgery ● Volume 129, Number 2 289
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was replaced.
Our series of 76 patients consisted of very sick patients
who in addition to aortic and mitral valve dysfunction also
had extensive calcification of the mitral annulus, annular
abscess, small aortic and mitral annuli, or inadequate fibrous
tissue to secure a new prosthetic valve because of at least
two previous valve replacements. In the entire group, 55
patients had undergone one or more previous valve replace-
ments.
The operative procedure failed in 13 of 68 patients who
survived the initial operation. In 1 patient, the diagnosis of
pericardial patch or valve dehiscence was made 11 years
postoperatively, and reoperation was not offered because of
the prohibitively high operative risk posed by comorbidi-
ties. This patient died of heart failure. The remaining 12
patients underwent a total of 15 reoperations. One patient
received a heart transplant elsewhere for late patch or valve
dehiscence and died. We performed the remaining 14 reop-
erations: 7 were for prosthetic valve endocarditis (5 early
and 2 late), 6 for patch or valve dehiscence (3 early and 3
late), and 1 for late bioprosthetic valve failure.
There was a high rate of early infection, probably related
to the amount of prosthetic material introduced at the time
of surgery, the duration of the operative procedure, and the
clinical status of the patients before surgery. There were
also 3 early failures, which were related to technical errors.
Indeed, this complication decreased as the experience in-
creased. Another important point is that glutaraldehyde-
preserved bovine pericardium calcifies when used as a patch
for reconstruction of the posterior mitral annulus and may
rupture. Dacron polyester fabric graft is probably a better
material for this purpose.
In summary, reconstruction of the intervalvular fibrous
body during aortic and mitral valve replacement was a
useful operative procedure in patients with complex heart
valve pathology. The operative mortality was relatively low
and decreased with experience. Infective endocarditis and
technical failures were common early on but also decreased
with experience. The long-term outcomes were satisfactory,
but continuous surveillance of these patients was needed
because of late patch or valve dehiscence.
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Discussion
Dr Kent W. Jones (Salt Lake City, Utah). I think this group in
Toronto have been leaders in surgical treatment of valvular heart
disease for a long time, and we are honored to have that group
present a study at our meeting. Dr De Oliveira, I have a few
questions. Have you considered in this group of patients using an
aortic homograft with the retained anterior mitral leaflet to repair
this area of the interfibrous body, rather than using the pericardial
patch as you described?
Dr De Oliveira. No. The principles that we use to treat infec-
tive endocarditis are radical resection of all the infected tissue and
all the inflamed tissue and then reconstruction with a patch. We do
not use aortic homografts for reconstruction. For this patient pop-
ulation, who sometimes had multiple previous operations, you just
need more patch material to be able to reconstruct the inflow and
outflow of the ventricle, I believe.
Dr Jones. Have you used biologic glue for the anchoring of this
pericardial patch, especially on the patients such as you described
with the posterior mitral valve annulus that had to be decalcified
and then covered with the pericardial patch? Did you use pericar-
dial glue at all in that group?
Dr De Oliveira. The biologic glue is used rarely, and not to fix
the patch. Occasionally when we finish the reconstruction of the
dome of the left atrium, we just put some biologic glue over the
suture line but not necessarily in the intervalvular fibrous area.
Dr Jones. In the article, but you didn’t present it here, it
appeared that about, as I recall, two thirds of the patients received
mechanical prostheses and one third bioprostheses. What led to
that decision?
Dr De Oliveira. That’s a very good question. The bottom line
is, I think, a decision made on the basis of what we know about the
use of prosthetic and mechanical valves.
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